Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Arena Pharmaceuticals (ARNA): I'd stay away from this one, said Cramer. It's not for me.
Advanced Micro Devices (AMD): This is a one trick pony, said Cramer.
Cheniere Energy (LNG): I like owning the Cheniere master limited partnership more, said Cramer.
Windstream Holdings (WIN): I don't trust this one, said Cramer. There are better places in the market to make money.
Ubiquiti Networks (UBNT): I'm sticking with it, said Cramer.
Columbia Banking System (COLB): I like it for the long-term, said Cramer. It's a winner.
Apple (AAPL): Lately, I've come to view Apple as the Rodney Dangerfield of stocks, said Cramer. It doesn't get any respect.
Weatherford Int'l (WFT): All I can say is, it's not as bad as it used to be, said Cramer. In the space I like Schlumberger much more.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the "Mad Money" website? firstname.lastname@example.org
Is this breakout story on your radar? "Mad Money" host Jim Cramer is about to put it there.
Jim Cramer is always looking for the next big biotech stock. He has found one that is a real game-changer, thanks to this new drug.
Jim Cramer does not want interest rates to rise right now, and lays out the significant repercussions on the globe if they do go up.
Jim Cramer is seeing some good signs in the economy right now. Could they be the perfect ingredients for a Santa Claus rally?
Grab the latest CNBC gear from the NBCUniversal Store!
Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.
You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.